Health Care Archives - Page 3 of 478

2 minute read

Boston Scientific Adds Stroke Prevention To Vascular Portfolio Via Silk Road Medical’s $1.3B Deal

June 18, 10:02 AM

Boston Scientific to acquire Silk Road Medical for $1.26 billion, enhancing its vascular portfolio with Silk Road's TCAR system, a breakthrough in stroke prevention. Transaction closes in H2 2024.

BSX

2 minute read

AstraZeneca’s Combination Cancer Drug For Advanced Breast Cancer Study Flunks Late-Stage Trial

By Vandana Singh

June 18, 9:22 AM

AstraZeneca announced that the CAPItello-290 Phase 3 trial for Truqap (capivasertib) combined with paclitaxel in advanced or metastatic triple-negative breast cancer did not meet primary endpoints for overall survival.

AZN

1 minute read

Why Is Small-Cap Cancer-Focused Zentalis Pharma Stock Trading Lower On Tuesday?

By Vandana Singh

June 18, 8:44 AM

Zentalis Pharmaceuticals announced the FDA's partial clinical hold on azenosertib studies due to recent patient deaths.

ZNTL

2 minute read

FDA Approves Merck’s Pneumococcal Vaccine As First Shot Designed For Adults

By Vandana Singh

June 18, 8:05 AM

The FDA has approved Merck's Capvaxive, the first pneumococcal conjugate vaccine for adults, protecting against 21 strains of bacteria. Additionally, Merck's Keytruda received FDA approval for advanced endometrial carcinoma.

MRK

1 minute read

Taysha Gene Therapies Announced Longer-term Clinical Data From Ongoing REVEAL Phase 1/2 Adolescent And Adult Trial And Initial Clinical Data From REVEAL Phase 1/2 Pediatric Trial Of TSHA-102 In Rett Syndrome

By Benzinga Newsdesk

June 18, 7:40 AM

Durable improvements across consistent clinical domains in both adult and pediatric patients, including motor skills, communication/socialization, autonomic function, seizures, and an encouraging safety profile seen

TSHA

2 minute read

Vaxart Stock Is Moving Higher After The Bell: What’s Going On?

By Adam Eckert

June 17, 4:32 PM

Vaxart, a clinical-stage biotechnology company developing a range of oral recombinant vaccines, announced Monday that proceeds from a recent offering combined with reimbursements under its Project NextGen award are expected to extend the company's cash runway into 2026.

VXRT

2 minute read

Qiagen Unveils Plan For $1B Shareholder Returns, Major Product Launches

By Vandana Singh

June 17, 3:04 PM

QIAGEN announces a comprehensive growth strategy by 2028. The plan includes significant shareholder returns, new product launches, and a focus on digital and diagnostic advancements.

QGEN

1 minute read

Why Is Pfizer Partner BioNTech Stock Trading Lower On Monday?

By Vandana Singh

June 17, 1:22 PM

BioNTech partner MediLink Therapeutics faces a partial clinical hold from the FDA on the Phase 1 trial of BNT326/YL202 for advanced non-small cell lung cancer and HR+/HER2-negative breast cancer.

BNTX

2 minute read

Pfizer’s COVID-19 Vaccine Safety Claims Under Lens, Faces Lawsuit From Kansas For Alleged Misleading Claims

By Vandana Singh

June 17, 1:13 PM

Kansas has filed a lawsuit against Pfizer, Inc., alleging the company misled the public about the safety and effectiveness of its COVID-19 vaccine, resulting in consumer protection violations and record revenues.

PFE